Oxford Nanopore Technologies (ONT) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Mar 2022 12:30 PM
RNS
Holding(s) in Company
08 Mar 2022 07:03 AM
RNS
Publication: Nanopore IDs >50 genetic diseases
01 Mar 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
24 Feb 2022 07:00 AM
RNS
Notice of Results
11 Feb 2022 05:30 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
01 Feb 2022 05:00 PM
RNS
Issue of Equity and Total Voting Rights
24 Jan 2022 03:00 PM
RNS
Appointment of Senior Independent Director
18 Jan 2022 01:00 PM
RNS
Holding(s) in Company
13 Jan 2022 07:00 AM
RNS
Fastest human genome sequence uses Oxford Nanopore
11 Jan 2022 06:00 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
07 Jan 2022 12:00 PM
RNS
Update to FY21 revenue guidance
07 Jan 2022 07:00 AM
RNS
Company to present at JP Morgan Healthcare conf
04 Jan 2022 06:30 PM
RNS
Issue of Equity and Total Voting Rights
20 Dec 2021 05:00 PM
RNS
Holding(s) in Company
13 Dec 2021 06:15 PM
RNS
Share Incentive Plan - Director/PDMR Shareholding
02 Dec 2021 07:00 AM
RNS
Oxford Nanopore announces technology updates
01 Dec 2021 07:00 AM
RNS
Issue of Equity and Total Voting Rights
09 Nov 2021 07:03 AM
RNS
Update to revenue guidance
03 Nov 2021 06:00 PM
RNS
Holding(s) in Company
01 Nov 2021 06:30 PM
RNS
PDMR Notification (ESPP) and Director Declaration
01 Nov 2021 07:00 AM
RNS
Issue of Equity and Total Voting Rights
14 Oct 2021 05:33 PM
RNS
Upgrade to full-year revenue guidance
13 Oct 2021 06:20 PM
RNS
Share Incentive Plan, Director/PDMR Transactions
08 Oct 2021 12:00 PM
RNS
Exercise of Over-allotment Option
08 Oct 2021 07:00 AM
RNS
Total Voting Rights
08 Oct 2021 07:00 AM
RNS
Notification of Transactions of Director/PDMR
07 Oct 2021 06:00 PM
RNS
Holding(s) in Company
07 Oct 2021 06:00 PM
RNS
Holding(s) in Company
07 Oct 2021 06:00 PM
RNS
Holding(s) in Company
05 Oct 2021 03:45 PM
RNS
Total Voting Rights
05 Oct 2021 03:45 PM
RNS
Block Listing Application/Directorate Change
05 Oct 2021 07:00 AM
RNS
Admission to Trading on the London Stock Exchange
04 Oct 2021 05:51 PM
RNS
Exercise of Over-allotment Option
30 Sep 2021 01:13 PM
RNS
Approval and Publication of Prospectus
30 Sep 2021 07:00 AM
RNS
Announcement of Offer Price
20 May 2004 06:09 PM
RNS
Holding(s) in Company
06 May 2004 03:35 PM
RNS
Directorate Change
30 Apr 2004 04:43 PM
RNS
Cancellation of admission
23 Mar 2004 05:44 PM
RNS
Holding(s) in Company
18 Mar 2004 12:00 PM
RNS
Result of AGM
03 Mar 2004 11:36 AM
RNS
Rule 2.10 Announcement
20 Feb 2004 05:22 PM
RNS
Holding in Company
18 Feb 2004 12:40 PM
RNS
Holding in Company
12 Feb 2004 04:22 PM
RNS
Holding in Company
05 Feb 2004 07:00 AM
PRN
Re Contract
16 Jan 2004 11:14 AM
RNS
Holding(s) in Company
13 Jan 2004 02:54 PM
RNS
Grant of Options
12 Jan 2004 05:32 PM
RNS
Holding in Company
09 Jan 2004 09:42 AM
PRN
Director Shareholding
08 Jan 2004 10:15 AM
PRN
EGM Statement

Oxford Nanopore Technologies develops electronic sensing systems for analyzing DNA, RNA, proteins, and other molecules including DNA sequencing, diagnostics and drug development using uses nanopore science to develop single-molecule sensing systems. Their products are used in research areas such as microbiology, human genetics, cancer research, and plant research.

Founded in 2005 as a spin-out from the University of Oxford, Oxford Nanopore is listed in London under the ticker ONT.

Oxford Nanopore share price listed at 615p in 2021.

UK 100